Benefits at a Glance
Less peripheral blood in the sample
Single acquisition site
20 minute procedure
Low discomfort for the patient
Average 3000 CFU’s per ml
Very low host morbidity
Qualifies under newly released FDA Guidance criteria**
How It Works
MARROW CELLUTION™ maximizes stem & progenitor cell recovery while minimizing peripheral blood infiltration. Because fluid under force follow the path of least resistance, traditional trocar needles with side ports aspirate primarily through the distal end of the cannula. This leads to excessive blood collection, requiring additional manipulation (i.e. centrifugation or chemical separation in a laboratory).
A traditional trocar needle aspirates primarily peripheral blood.
MARROW CELLUTION™ accesses aspirate flow collected exclusively laterally as the tip of the aspiration cannula is closed, allowing marrow collection perpendicular to and around the channel created by the device. It incorporates technology to precisely reposition the harvesting cannula within the marrow space after each aspiration. These features achieve a clinicians’ desire for a single entry point.
MARROW CELLUTION™ aspirates from multiple geographies while limiting peripheral blood collection.